DSIP is a tiny sleep peptide with a big question mark — here is what the studies measured.

Start here

Let's keep this simple. DSIP stands for delta sleep-inducing peptide, a tiny chain of nine amino acids (the building blocks that make up proteins). Scientists first pulled it from the blood of sleeping rabbits in 1977 and named it for the slow, deep "delta" brain waves it boosted when they dripped it into the brain ^[1]. People interested in better sleep, calmer stress, and recovery talk about it because of that name.

Here is the honest part most pages skip. After more than forty years, nobody has found the receptor DSIP attaches to, the gene that makes it, or a clear mechanism for what it does ^[3]. The human studies are small, mostly from the 1980s, and have not been repeated in modern trials. Many people who try it feel nothing. So treat this site as a careful tour of the evidence — what people report, including the downsides, is on the effects page — not a promise that DSIP will do anything for you.

What DSIP is, in one paragraph

DSIP is an endogenous neuropeptide — "endogenous" just means your body already makes small amounts of it, and a "neuropeptide" is a short protein-like signal used in the nervous system. Its sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, nine amino acids in a row, with a molecular weight of about 849 daltons ^[1]. It turns up in plasma, spinal fluid, and even milk, usually stuck to a carrier protein. It also has a formal drug name, Emideltide, assigned by the international naming body — but no Emideltide product has ever been approved or sold by any regulator, anywhere. DSIP is not approved by the FDA for any use. It exists today as a research chemical and an unsolved biological curiosity.

What the studies actually found

The headline finding is the one in the name: infused directly into an animal brain, DSIP enhanced delta and spindle brain-wave activity, the electrical signatures of deep sleep ^[1]. In a small 1981 study, six middle-aged people with chronic insomnia got synthetic DSIP into a vein and slept longer, woke up fewer times, and reported no next-day grogginess, with the benefit showing up in the second hour after the injection ^[2].

Then the picture gets messier. A 2024 mouse study using a re-engineered version of DSIP built to cross into the brain cut wakefulness by about 31% and restored sleep-related brain chemicals ^[6] — but that was a modified molecule, not plain DSIP. And a sweeping 2006 review concluded the sleep evidence was "extremely poorly documented and still weak," noting that lab-made DSIP look-alikes, not natural DSIP, drove the clearest effects ^[3]. Strong signals and shrugs sit side by side in this literature. If you are new to it, the delta sleep inducing peptide explainer covers the basics first.

Beyond sleep: the other things researchers tested

DSIP picked up a long list of side investigations. Small European pilot studies in the 1980s tried it for alcohol and opiate withdrawal, reporting that 48 of 49 patients improved in one open trial, with the authors guessing at an opioid-system link ^[7]. Another pilot reported pain relief in six of seven patients with chronic pain ^[9]. Russian aging research using a DSIP-containing preparation reported longer lifespan and fewer tumors in mice ^[5].

Every one of these is small, old, or from a narrow set of labs, and several were never controlled. They are interesting leads, not settled facts. You can read the DSIP research page for the mechanism and the studies in detail, and the DSIP peptide side effects page for what can go wrong.

Where this site stands

DSIP Source is an independent editorial project. We summarize the published science — we are not a clinic, we sell nothing, and nothing here is medical advice. The whole point of this digest is to give you the real shape of the evidence: a genuinely intriguing peptide with a famous name, a handful of encouraging old human studies, a mechanism nobody has solved, and a response rate that is, by community accounts, closer to a coin flip than a sure thing. If you want the human-experience side first, including who should be careful, start with DSIP effects.